Clinical Trials Browser

Phase 1 × INDUSTRY × Adrenocortical Carcinoma × Clear all

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Desmoid Tumors, Adrenocortical Carcinoma

NCT07189403 2026-02-24

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Phase 1 Recruiting

40 enrolled

Endocrine

Adrenocortical Carcinoma

NCT03746431 2026-01-07

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Phase 1 Terminated

78 enrolled

BreastDermatologicEndocrineGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05999292 2024-12-09

Phase 1 Study of 68Ga-R8760

Phase 1 Terminated

11 enrolled

Endocrine

Adrenocortical Carcinoma

NCT04373265 2024-02-23

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

Phase 1 Completed

15 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, Diabetes Mellitus, Type 2, Endocrine System Diseases, Hyperglycemia, Hypertension, Pathologic Processes, Glucose Intolerance, Adrenocortical Carcinoma

NCT02637531 2022-04-04

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Phase 1 Unknown

219 enrolled

BreastDermatologicEndocrineOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT03145909 2018-11-29

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Phase 1 Terminated

19 enrolled

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT01898715 2017-11-06

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Phase 1 Completed

63 enrolled

Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT01832974 2015-04-27

Possible New Therapy for Advanced Cancer

Phase 1 Terminated

9 enrolled

Endocrine

Adrenal Gland Neoplasms, Neoplasm Metastasis, Adrenocortical Carcinoma

Clinical Trials

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Phase 1 Study of 68Ga-R8760

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Possible New Therapy for Advanced Cancer